Biophoton therapy for patients with brain disorders

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of biophoton therapy on patients suffering from various brain disorders, including Alzheimer's disease, dementia, Parkinson's disease, and traumatic brain injury. Participants will stay at the Tesla MedBed Center for 4 to 6 weeks, where they will be randomly assigned to either a treatment group receiving biophoton generators or a placebo group. The study employs a triple-blinded, placebo-controlled design to ensure the validity of the results, with participants using the assigned devices during sleep for the first two weeks. After this period, participants may be switched to the treatment group based on their initial assignment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Must meet conditions for approval.
* Must be 18-years or older and stay in a hotel.
* Must have a caregiver willing to support the participant's full involvement in the study. • The caregiver can assist in completing all study surveys.
* Can provide informed consent or can be assisted by caregiver.
* Can provide a clinical diagnosis of a brain disorder.
* Can complete all study procedures during the study.
* Must be fluent in English (or the Caregiver can fully translate).
* Women of childbearing age must provide results of a pregnancy test in order to participate.

Exclusion Criteria:

* Any untreated mental illnesses, that would affect study participation. This will be judged by the caregiver, or by the clinical study medical expert.
* Someone that relies on a ventilator.
* Someone who has a deep brain stimulator, pacemaker, or any implanted electronic devices.
* Co-morbid conditions that would interfere with study activities or response to treatment, which may include severe chronic pulmonary disease, history of uncontrolled seizures, acute or chronic infectious illness, severe diabetes, kidney failure, or any end-of-life prognosis.
* Is participating in another investigational drug or device trial.
* Has an active infectious disease, such as COVID-19.
* Pregnant women.

Where it's running

• Tesla MedBed Center, 139 Pittsburgh Road, Butler, PA 16001
  Butler, Pennsylvania, United States Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Biophoton therapy for chronic severe arthritis pain relief

  This study is testing if biophoton therapy can help people with chronic severe arthritis pain feel better over 12 weeks.

  Recruiting First Institute of All Medicines · Butler, Pennsylvania · NCT06915012

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.